▶ 調査レポート

世界の陰茎がん市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Penile Cancer Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の陰茎がん市場 2021:企業別、地域別、種類・用途別 / Global Penile Cancer Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-2104Z10703資料のイメージです。• レポートコード:GIR-2104Z10703
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥504,600 (USD3,480)▷ お問い合わせ
  Multi User¥756,900 (USD5,220)▷ お問い合わせ
  Corporate User¥1,009,200 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、陰茎がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。陰茎がんの種類別市場規模(放射線療法、化学療法、生物学的療法、手術)、用途別市場規模(病院、診療所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・陰茎がんの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Merck、GlaxoSmithKline、Pfizer、Bristol-Myers Squibb、Roche、Novartis
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:放射線療法、化学療法、生物学的療法、手術
・用途別分析2016年-2026年:病院、診療所、その他
・陰茎がんの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・陰茎がんのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・陰茎がんのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・陰茎がんの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・陰茎がんの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Penile Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Penile Cancer size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Penile Cancer market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Penile Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Radiation Therapy
Chemotherapy
Biological Therapy
Surgery

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
Merck
GlaxoSmithKline
Pfizer
Bristol-Myers Squibb
Roche
Novartis

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Penile Cancer
1.2 Classification of Penile Cancer by Type
1.2.1 Overview: Global Penile Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Penile Cancer Revenue Market Share by Type in 2020
1.2.3 Radiation Therapy
1.2.4 Chemotherapy
1.2.5 Biological Therapy
1.2.6 Surgery
1.3 Global Penile Cancer Market by Application
1.3.1 Overview: Global Penile Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Penile Cancer Market Size & Forecast
1.5 Global Penile Cancer Market Size and Forecast by Region
1.5.1 Global Penile Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Penile Cancer Market Size by Region, (2016-2021)
1.5.3 North America Penile Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Penile Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Penile Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Penile Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Penile Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Penile Cancer Market Drivers
1.6.2 Penile Cancer Market Restraints
1.6.3 Penile Cancer Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Penile Cancer Product and Solutions
2.1.4 Merck Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Penile Cancer Product and Solutions
2.2.4 GlaxoSmithKline Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Penile Cancer Product and Solutions
2.3.4 Pfizer Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Penile Cancer Product and Solutions
2.4.4 Bristol-Myers Squibb Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Penile Cancer Product and Solutions
2.5.4 Roche Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Penile Cancer Product and Solutions
2.6.4 Novartis Penile Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Penile Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Penile Cancer Players Market Share
3.2.2 Top 10 Penile Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Penile Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Penile Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Penile Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Penile Cancer Revenue Market Share by Application (2016-2021)
5.2 Penile Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Penile Cancer Revenue by Type (2016-2026)
6.2 North America Penile Cancer Revenue by Application (2016-2026)
6.3 North America Penile Cancer Market Size by Country
6.3.1 North America Penile Cancer Revenue by Country (2016-2026)
6.3.2 United States Penile Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Penile Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Penile Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Penile Cancer Revenue by Type (2016-2026)
7.2 Europe Penile Cancer Revenue by Application (2016-2026)
7.3 Europe Penile Cancer Market Size by Country
7.3.1 Europe Penile Cancer Revenue by Country (2016-2026)
7.3.2 Germany Penile Cancer Market Size and Forecast (2016-2026)
7.3.3 France Penile Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Penile Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Penile Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Penile Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Penile Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Penile Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Penile Cancer Market Size by Region
8.3.1 Asia-Pacific Penile Cancer Revenue by Region (2016-2026)
8.3.2 China Penile Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Penile Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Penile Cancer Market Size and Forecast (2016-2026)
8.3.5 India Penile Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Penile Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Penile Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Penile Cancer Revenue by Type (2016-2026)
9.2 South America Penile Cancer Revenue by Application (2016-2026)
9.3 South America Penile Cancer Market Size by Country
9.3.1 South America Penile Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Penile Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Penile Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Penile Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Penile Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Penile Cancer Market Size by Country
10.3.1 Middle East & Africa Penile Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Penile Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Penile Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Penile Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Penile Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Penile Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Penile Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Penile Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Penile Cancer Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Penile Cancer Product and Solutions
Table 9. Merck Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Penile Cancer Product and Solutions
Table 13. GlaxoSmithKline Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Penile Cancer Product and Solutions
Table 17. Pfizer Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Penile Cancer Product and Solutions
Table 21. Bristol-Myers Squibb Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Penile Cancer Product and Solutions
Table 25. Roche Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Penile Cancer Product and Solutions
Table 29. Novartis Penile Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Penile Cancer Revenue (USD Million) by Players (2019-2021)
Table 31. Global Penile Cancer Revenue Share by Players (2019-2021)
Table 32. Breakdown of Penile Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Penile Cancer Players Head Office, Products and Services Provided
Table 34. Penile Cancer Mergers & Acquisitions in the Past Five Years
Table 35. Penile Cancer New Entrants and Expansion Plans
Table 36. Global Penile Cancer Revenue (USD Million) by Type (2016-2021)
Table 37. Global Penile Cancer Revenue Share by Type (2016-2021)
Table 38. Global Penile Cancer Revenue Forecast by Type (2021-2026)
Table 39. Global Penile Cancer Revenue by Application (2016-2021)
Table 40. Global Penile Cancer Revenue Forecast by Application (2021-2026)
Table 41. North America Penile Cancer Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Penile Cancer Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Penile Cancer Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Penile Cancer Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Penile Cancer Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Penile Cancer Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Penile Cancer Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Penile Cancer Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Penile Cancer Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Penile Cancer Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Penile Cancer Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Penile Cancer Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Penile Cancer Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Penile Cancer Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Penile Cancer Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Penile Cancer Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Penile Cancer Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Penile Cancer Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Penile Cancer Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Penile Cancer Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Penile Cancer Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Penile Cancer Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Penile Cancer Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Penile Cancer Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Penile Cancer Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Penile Cancer Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Penile Cancer Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Penile Cancer Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Penile Cancer Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Penile Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Penile Cancer Picture
Figure 2. Global Penile Cancer Revenue Market Share by Type in 2020
Figure 3. Radiation Therapy
Figure 4. Chemotherapy
Figure 5. Biological Therapy
Figure 6. Surgery
Figure 7. Penile Cancer Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Penile Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Penile Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Penile Cancer Revenue Market Share by Region (2016-2026)
Figure 14. Global Penile Cancer Revenue Market Share by Region in 2020
Figure 15. North America Penile Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Penile Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Penile Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Penile Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Penile Cancer Market Drivers
Figure 20. Penile Cancer Market Restraints
Figure 21. Penile Cancer Market Trends
Figure 22. Merck Recent Developments and Future Plans
Figure 23. GlaxoSmithKline Recent Developments and Future Plans
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 29. Global Penile Cancer Revenue Share by Players in 2020
Figure 30. Penile Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Penile Cancer Revenue Market Share in 2020
Figure 32. Global Top 10 Players Penile Cancer Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Penile Cancer Revenue Share by Type in 2020
Figure 35. Global Penile Cancer Market Share Forecast by Type (2021-2026)
Figure 36. Global Penile Cancer Revenue Share by Application in 2020
Figure 37. Global Penile Cancer Market Share Forecast by Application (2021-2026)
Figure 38. North America Penile Cancer Sales Market Share by Type (2016-2026)
Figure 39. North America Penile Cancer Sales Market Share by Application (2016-2026)
Figure 40. North America Penile Cancer Revenue Market Share by Country (2016-2026)
Figure 41. United States Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Penile Cancer Sales Market Share by Type (2016-2026)
Figure 45. Europe Penile Cancer Sales Market Share by Application (2016-2026)
Figure 46. Europe Penile Cancer Revenue Market Share by Country (2016-2026)
Figure 47. Germany Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Penile Cancer Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Penile Cancer Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Penile Cancer Revenue Market Share by Region (2016-2026)
Figure 55. China Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Penile Cancer Sales Market Share by Type (2016-2026)
Figure 62. South America Penile Cancer Sales Market Share by Application (2016-2026)
Figure 63. South America Penile Cancer Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Penile Cancer Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Penile Cancer Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Penile Cancer Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Penile Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source